Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Hypertension

New treatment target for systolic blood pressure?

Nature Reviews Nephrology volume 5, pages 675–676 (2009)Cite this article

The degree to which systolic blood pressure should be lowered in individuals with mild hypertension is unclear. The Cardio-Sis trial has investigated whether tight systolic blood pressure control is more beneficial than usual control in individuals with hypertension but without diabetes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Symonds, B. The blood pressure of healthy men and women. JAMA 80, 232–236 (1923).

    Article  Google Scholar 

  2. Kearney, P. M. et al. Global burden of hypertension: analysis of worldwide data. Lancet 365, 217–223 (2005).

    Article  Google Scholar 

  3. Fisher, J. W. Proceedings of the Association of Life Insurance Medical Directors 7, 21 (1920–1921).

  4. Kempner, W. Radical dietary treatment of hypertensive and arteriosclerotic vascular disease, heart and kidney disease, and vascular retinopathy. GP 9, 71–92 (1954).

    CAS  PubMed  Google Scholar 

  5. [No authors listed] Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202, 1028–1034 (1967).

  6. [No authors listed] Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 242, 2562–2571 (1979).

  7. Kalaitzidis, R. & Bakris, G. L. Lower blood pressure goals for cardiovascular and renal risk reduction: are they defensible? J. Clin. Hypertens. (Greenwich) 11, 345–347 (2009).

    Article  Google Scholar 

  8. Verdecchia, P. et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet 374, 525–533 (2009).

    Article  Google Scholar 

  9. Moritz, A. & Oldt, M. Arteriolar sclerosis in hypertensive and nonhypertensive individuals. Am. J. Pathol. 13, 679–728 (1937).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Sanchez-Lozada, L. G., Tapia, E., Johnson, R. J., Rodriguez-Iturbe, B. & Herrera-Acosta, J. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int. Suppl. 64, S9–S14 (2003).

    Article  Google Scholar 

  11. Simon, G. Why do treated hypertensives suffer strokes? An internist's perspective. J. Clin. Hypertens. (Greenwich) 4, 338–344 (2002).

    Article  Google Scholar 

  12. Hill, G. S., Heudes, D., Jacquot, C., Gauthier, E. & Bariety, J. Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int. 69, 823–831 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Renal Diseases and Hypertension, University of Colorado, Denver, CO, USA

    Richard J. Johnson

  2. Department of Nephrology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City

    Laura G. Sánchez-Lozada

  3. Servicio de Nefrología, Hospital Universitario and Universidad del Zulia, IVIC-Zulia, Maracaibo, Venezuela

    Bernardo Rodríguez-Iturbe

Authors
  1. Richard J. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura G. Sánchez-Lozada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernardo Rodríguez-Iturbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard J. Johnson.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnson, R., Sánchez-Lozada, L. & Rodríguez-Iturbe, B. New treatment target for systolic blood pressure?. Nat Rev Nephrol 5, 675–676 (2009). https://doi.org/10.1038/nrneph.2009.188

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2009.188

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing